Eltrombopag, low-dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia

被引：23
|
作者：
Gomez-Almaguer, David [1 ,2 ]
Colunga-Pedraza, Perla R. [1 ,2 ]
Gomez-De Leon, Andres [1 ,2 ]
Gutierrez-Aguirre, Cesar H. [1 ,2 ]
Cantu-Rodriguez, Olga G. [1 ,2 ]
Jaime-Perez, Jose C. [1 ,2 ]
机构：
[1] Univ Autonoma Nuevo Leon, Fac Med, Monterrey, Nuevo Leon, Mexico
[2] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Haematol Serv, Monterrey, Nuevo Leon, Mexico
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2019年 / 184卷 / 02期
关键词：
immune thrombocytopenia; eltrombopag; rituximab; dexamethasone; THERAPY;
D O I：
10.1111/bjh.15070
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：288 / 290
页数：3
相关论文
共 50 条
  • [21] Carfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myeloma
    Dytfeld, Dominik
    Jasielec, Jagoda
    Griffith, Kent A.
    Lebovic, Daniel
    Vesole, David H.
    Jagannath, Sundar
    Al-Zoubi, Ammar
    Anderson, Tara
    Detweiler-Short, Kristen
    Stockerl-Goldstein, Keith
    Ahmed, Asra
    Jobkar, Terri
    Durecki, Diane E.
    McDonnell, Kathryn
    Mietzel, Melissa
    Couriel, Daniel
    Kaminski, Mark
    Vij, Ravi
    Jakubowiak, Andrzej J.
    HAEMATOLOGICA, 2014, 99 (09) : E162 - E164
  • [22] Experience with high dose dexamethasone in the treatment of chronic symptomatic immune thrombocytopaenia
    Van Riet, FAD
    Wessels, G
    Hesseling, PB
    EAST AFRICAN MEDICAL JOURNAL, 1999, 76 (10) : 571 - 574
  • [23] Treatment of newly diagnosed, inner-city multiple myeloma patients with low-dose thalidomide in combination with dexamethasone and zoledronate: A phase II trial.
    Klueppelberg, U
    Shapira, I
    Smith, E
    Braunstein, M
    Kahn, D
    Pertsovsky, Y
    Batuman, C
    BLOOD, 2005, 106 (11) : 379B - 379B
  • [24] Treatment outcome with the combination of carfilzomib, lenalidomide, and low-dose dexamethasone (CRd) for newly diagnosed multiple myeloma (NDMM) after extended follow-up
    Jakubowiak, Andrzej J.
    Dytfeld, Dominik
    Griffith, Kent A.
    Jasielec, Jagoda
    McDonnell, Kathryn
    Lebovic, Daniel
    Vesole, David H.
    Jagannath, Sundar
    Chottiner, Elaine G.
    Anderson, Tara B.
    Detweiler-Short, Kristen
    Stockerl-Goldstein, Keith
    Ahmed, Asra Z.
    Jobkar, Terri L.
    Durecki, Diane E.
    Mietzel, Melissa A.
    Couriel, Daniel R.
    Vij, Ravi
    Kaminski, Mark Stefan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [25] Long-term treatment of newly-diagnosed multiple myeloma with low-dose thalidomide, dexamethasone and zoledronate (TDZ).
    Klueppelberg, U
    Shapira, I
    Chen, L
    Aloba, MC
    Smith, E
    Palanisamy, N
    Schmidt, J
    Moezi, M
    Batuman, O
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 608S - 608S
  • [26] EFFICACY OF RITUXIMAB IN COMBINATION WITH DEXAMETHASONE VS DEXAMETHASONE IN NEWLY DIAGNOSED PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA - AN INTERIM ANALYSIS OF A PROSPECTIVE RANDOMISED STUDY
    Gudbrandsdottir, S.
    Frederiksen, H.
    Helleberg, I.
    Jensen, B.
    Kjeldsen, L.
    Klausen, T.
    Larsen, H.
    Mounts-Andersen, H. T.
    Nielsen, C. H.
    Nielsen, O. J.
    Plesner, T.
    Pulczynski, S.
    Roennow-Jessen, D.
    Hasselbalch, H. C.
    Birgens, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 253 - 253
  • [27] A Prospective Study to Evaluate the Efficacy, Safety and Response Duration of Newly Diagnosed Adult Immune Thrombocytopenia Patients Treated with Low Dose Rituximab and High Dose of Dexamethasone
    Dolai, Tuphan Kanti
    Mukherjee, Soumya
    Mandal, Prakas Kumar
    De, Rajib
    Chakrabarti, Prantar
    BLOOD, 2016, 128 (22)
  • [28] Bortezomib, Lenalidomide and Low-Dose Dexamethasone (VRD) Versus Lenalidomide and Low-Dose Dexamethasone (Ld) for Newly-Diagnosed Multiple Myeloma- a Randomized Phase III Study
    Mookerjee, Anjali
    Gupta, Ritu
    Jasrotia, Shivali
    Sahoo, Ranjit
    Kumar, Rakesh
    Thulkar, Sanjay
    Sharma, Om Dutt
    Kumar, Lalit
    BLOOD, 2017, 130
  • [29] Low-dose rituximab in immune thrombocytopenia: One and done
    Beltrami-Moreira, Marina
    Bussel, James B.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (04) : 388 - 389
  • [30] Lenalidomide and low-dose dexamethasone in Japanese patients with newly diagnosed multiple myeloma: A phase II study
    Suzuki, Kenshi
    Shinagawa, Atsushi
    Uchida, Toshiki
    Taniwaki, Masafumi
    Hirata, Hirokazu
    Ishizawa, Kenichi
    Matsue, Kosei
    Ogawa, Yoshiaki
    Shimizu, Takayuki
    Otsuka, Maki
    Matsumoto, Morio
    Iida, Shinsuke
    Terui, Yasuhito
    Matsumura, Itaru
    Ikeda, Takashi
    Takezako, Naoki
    Ogaki, Yumi
    Midorikawa, Shuichi
    Houck, Vanessa
    Ervin-Haynes, Annette
    Chou, Takaaki
    CANCER SCIENCE, 2016, 107 (05) : 653 - 658
12345